brentuximab vedotin
takeda,seagen
['lymphoma', 'echelon-1', 'brentuximab vedotin', 'hodgkin']
addition of brentuximab vedotin to first-line regimen extends survival, lowers risk for death among patients with advanced classical hodgkin #lymphoma read more from the randomized phase 3 echelon-1 trial: #asco22 #oncology 
The content you need, when you need it.